FFLV Fees and Costs — Fidelity Fundamental Large Cap Value ETF

Data updated: 2026-10-13

The net expense ratio is 0.38%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $2K in broker commissions, 0.0126% of average net assets, and portfolio turnover was 44%.

FFLV Fees and Expenses

Annual operating expenses and sales charges of FFLV. Prospectus, as of November 30, 2025.

Annual operating expenses
Management fee0.38%
12b-1 fee0.00%
Other expenses0.00%
Gross expense ratio0.38%
Fee waiver—
Net expense ratio0.38%
Sales charges
Max front load—
Max deferred load—
Redemption fee—

FFLV Costs Over Time

On $10,000 invested in FFLV, assuming 5% a year before costs, total costs come to $249 over 5 years, cutting the return by 0.41% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.38%)$40$125$219
Trading costs (broker commissions)$1$4$7
Lost growth on money paid in costs$0$6$23
Total costs$41$136$249
Value after costs$10,459$11,440$12,514
Impact on return, per year0.41%0.41%0.41%

FFLV Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2026.

  • Explicit cost rate (commissions ÷ average net assets): 0.0126%
  • Total broker commissions: $2K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 44%

FFLV Agency Brokers

Commissions paid.

BrokerAmountShare
GOLDMAN SACHS GROUP INC (THE)$26717.39%
BANK OF AMERICA CORPORATION$24916.18%
JPMORGAN CHASE and CO$20713.47%
JEFFERIES FINANCIAL GROUP INC$17211.18%
UBS GROUP AG$1529.91%
VIRTU FINANCIAL INC$1127.31%
BARCLAYS PLC$1117.25%
MORGAN STANLEY$1087.00%
BNP PARIBAS$875.64%
ROYAL BANK OF CANADA$724.68%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.